About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72804 record(s)
Req # A-2020-001613
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-115165-386.Organization: Health Canada
January 2024
Req # A-2021-000440
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-100203-189, Status of the use of Remotely Piloted Aircraft Systems (drones) for pesticide application in Canada.Organization: Health Canada
January 2024
Req # A-2021-001103
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-075341-120.Organization: Health Canada
January 2024
Req # A-2021-001626
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_04099915, E2B_04220499, E2B_04291634, E2B_04207144, E2B_04127965, E2B_00900035, E2B_04205769, E2B_04306647, E2B_04309070, E2B_04337015, E2B_04337025, E2B_04325809, E2B_04325034,…Organization: Health Canada
January 2024
Req # A-2021-001787
Adverse Drug Reaction (ADR) for AGALSIDASE BETA. Report number: E2B_04595165.Organization: Health Canada
January 2024
Req # A-2021-001971
Adverse Drug Reactions (ADRs). Report numbers: 000637837, 000682834, E2B_02062357, 000715854, 000686654.Organization: Health Canada
January 2024
Req # A-2022-000123
Adverse Drug Reaction (ADR) for ALFUZOSIN HYDROCHLORIDE. Report number: E2B_05007203.Organization: Health Canada
January 2024
Req # A-2022-000132
Adverse Drug Reactions (ADRs). Report numbers: E2B_05040768, E2B_05047160, E2B_05045863, E2B_05040989, E2B_05045885, E2B_05047233, E2B_05047201, E2B_05046993 E2B_05040639, E2B_05046996.Organization: Health Canada
January 2024
Req # A-2022-000178
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-100947-72.Organization: Health Canada
January 2024
Req # A-2022-000350
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-102527-380.Organization: Health Canada
January 2024